Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson's disease symptoms

Acta Neurologica Scandinavica
Hui-Jun ZhangChun-Feng Liu

Abstract

Vitamin D deficiency is widespread in patients with Parkinson's disease (PD). Our aim was to determine whether serum vitamin D levels correlated with bone mineral density (BMD) and non-motor symptoms in patients with PD. A consecutive series of 182 patients with PD and 185 healthy controls were included. Serum 25-hydroxyvitamin D (25[OH]D) levels were measured by immunoassay, while BMD of the lumbar spine and femoral neck was measured by dual-energy X-ray absorptiometry. Associations between serum vitamin D levels and clinical data were evaluated using partial correlation analysis. Patients with PD had significantly lower serum 25(OH)D levels relative to healthy controls (49.75 ± 14.11 vs 43.40 ± 16.51, P < 0.001). Furthermore, PD patients with lower vitamin D levels had a significantly higher frequency of falls (P = 0.033) and insomnia (P = 0.015). They also had significantly higher scores for the Pittsburgh Sleep Quality Index (PSQI; P = 0.014), depression (P = 0.020), and anxiety (P = 0.009). Finally, patients with PD also had a significantly lower mean BMD of the lumbar spine (P = 0.011) and femoral neck (P < 0.001). After adjusting for age, sex, and body mass index, vitamin D levels significantly correlated with falls, ins...Continue Reading

References

Jan 1, 1990·Neuroepidemiology·D E LilienfeldP J Landrigan
Oct 1, 1993·International Journal of Epidemiology·E J Betemps, C R Buncher
Sep 1, 1997·Journal of the Neurological Sciences·D J Lanska
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·C AndersonP D Swanson
Jun 29, 2004·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·E MartignoniUNKNOWN Parkinson's Disease Comorbidity Study Group
Jul 20, 2006·Clinical Rheumatology·D J ArmstrongM B Finch
Jan 19, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Harold L Newmark, Jonathan Newmark
Jul 20, 2007·The New England Journal of Medicine·Michael F Holick
Sep 11, 2007·Acta Neurologica Scandinavica·B LorefältA-K Granérus
Feb 2, 2008·Journal of Physiological Anthropology·Naoto KamideHajime Miura
Oct 15, 2008·Archives of Neurology·Marian L EvattVin Tangpricha
Jul 14, 2010·Archives of Neurology·Paul KnektMarkku Heliövaara
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Mar 16, 2011·Archives of Neurology·Marian L EvattUNKNOWN Parkinson Study Group DATATOP Investigators
Aug 30, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Lauren R HarmsJohn J McGrath
Nov 8, 2012·Age and Ageing·Frederiek van den BosHarald J J Verhaar
Dec 18, 2012·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·David E McCartyAndrew A Marino
Mar 15, 2013·The American Journal of Clinical Nutrition·Masahiko SuzukiMitsuyoshi Urashima
Apr 5, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Amie L PetersonFay B Horak
Oct 2, 2013·Journal of Parkinson's Disease·Amie L PetersonJoseph F Quinn
Jan 8, 2014·Neuroscience Letters·Maria Skaalum PetersenJónrit Halling
Mar 13, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Kelli M TorsneyAndrew J Lees
Apr 25, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Y S ChaoP J Veugelers
Feb 25, 2015·Acta Neurologica Scandinavica·W JangH-T Kim
Nov 6, 2015·Current Treatment Options in Neurology·Anusha K YeshokumarEllen M Mowry
Jan 7, 2016·Neuro-degenerative Diseases·Ki Young KwonWooyoung Jang
Jan 13, 2016·Journal of Parkinson's Disease·Lisanne M RimmelzwaanElisabeth M W Eekhoff
Apr 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Srishti ShresthaHonglei Chen
Dec 18, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rosa CalvelloDario Domenico Lofrumento
Dec 20, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Qiqige AletengXin Gao
Sep 2, 2018·Journal of Neuroinflammation·Ludmila A R LimaGlauce S B Viana
Oct 28, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Natalia KrisanovaTatiana Borisova

❮ Previous
Next ❯

Citations

Jun 17, 2020·Frontiers in Neurology·Michelle E Fullard, John E Duda
Mar 27, 2020·Frontiers in Aging Neuroscience·Qing YeXiqun Chen
Nov 6, 2020·Nutritional Neuroscience·Michela BarichellaGianni Pezzoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.